Spanish Breast Cancer Group / Grupo Español de Investigación en Cáncer de Mama (GEICAM)
Scientific academy / society / association
Location:
Alcobendas,
Spain (ES)
ISNI: -
ROR: https://ror.org/05ygm7711
Show on Map:
Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping (2025)
Denkert C, Rachakonda S, Karn T, Weber K, Martin M, Marmé F, Untch M, et al.
Journal article
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study (2023)
Hurvitz SA, Bardia A, Quiroga V, Park YH, Blancas I, Alonso-Romero JL, Vasiliev A, et al.
Journal article
Neoadjuvant giredestrant (GDC-9545) + palbociclib (palbo) vs anastrozole (A) plus palbo in post-menopausal women with oestrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC): Interim analysis of the randomised, open-label, phase II coopERA BC study (2021)
Hurvitz SA, Park YH, Bardia A, Quiroga V, Lopez-Valverde V, Steinseifer J, Moore HM, et al.
Conference contribution